Effect of sodium-glucose co-transporter-2 inhibitors on impaired ventricular repolarization in people with Type 2 diabetes.
T SatoTakayuki MikiH OhnishiT YamashitaA TakadaT YanoM TannoA TsuchidaT MiuraPublished in: Diabetic medicine : a journal of the British Diabetic Association (2017)
The findings suggest that sodium-glucose co-transporter-2 inhibitor treatment reverses ventricular repolarization heterogeneity in people with Type 2 diabetes, independently of its effect on glycaemic control. The favourable effect on ventricular repolarization heterogeneity could be the mechanism by which empaglifozin reduced cardiovascular events in a recent study.